IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BERRUTI, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.957
AS - Asia 16.119
EU - Europa 11.579
SA - Sud America 3.506
AF - Africa 343
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 18
Totale 66.557
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.429
SG - Singapore 5.728
CN - Cina 4.996
BR - Brasile 2.905
UA - Ucraina 2.772
HK - Hong Kong 1.878
IT - Italia 1.728
DE - Germania 1.591
VN - Vietnam 1.201
PL - Polonia 975
FI - Finlandia 820
FR - Francia 777
GB - Regno Unito 703
RU - Federazione Russa 700
TR - Turchia 608
IE - Irlanda 520
BD - Bangladesh 489
IN - India 349
CA - Canada 267
AR - Argentina 234
EE - Estonia 191
MX - Messico 151
SE - Svezia 148
ID - Indonesia 145
IQ - Iraq 135
NL - Olanda 128
ZA - Sudafrica 120
JP - Giappone 118
CZ - Repubblica Ceca 113
ES - Italia 94
EC - Ecuador 92
AT - Austria 66
SA - Arabia Saudita 61
PK - Pakistan 60
BE - Belgio 57
VE - Venezuela 56
CO - Colombia 52
MA - Marocco 50
PY - Paraguay 50
UZ - Uzbekistan 49
CL - Cile 48
AE - Emirati Arabi Uniti 35
EG - Egitto 31
AU - Australia 29
CH - Svizzera 29
NG - Nigeria 29
KE - Kenya 28
DZ - Algeria 27
LT - Lituania 27
PE - Perù 26
JM - Giamaica 25
JO - Giordania 24
KZ - Kazakistan 23
UY - Uruguay 22
AZ - Azerbaigian 21
TN - Tunisia 20
AL - Albania 19
CR - Costa Rica 19
KR - Corea 19
NP - Nepal 19
PH - Filippine 19
IL - Israele 18
LB - Libano 18
EU - Europa 16
PT - Portogallo 16
BO - Bolivia 15
BG - Bulgaria 13
DK - Danimarca 13
PA - Panama 13
RO - Romania 13
HN - Honduras 12
TT - Trinidad e Tobago 11
ET - Etiopia 10
IR - Iran 10
KG - Kirghizistan 9
LV - Lettonia 9
MY - Malesia 9
TW - Taiwan 9
BB - Barbados 8
GR - Grecia 8
HU - Ungheria 8
OM - Oman 8
PS - Palestinian Territory 8
TH - Thailandia 8
BH - Bahrain 7
CY - Cipro 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
MD - Moldavia 6
MK - Macedonia 6
MU - Mauritius 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
SY - Repubblica araba siriana 5
AM - Armenia 4
GE - Georgia 4
GY - Guiana 4
KW - Kuwait 4
Totale 66.490
Salva come PNG Salva come JPEG
Città #
Fairfield 4.232
Woodbridge 3.240
Singapore 2.946
Ashburn 2.945
Houston 2.228
Jacksonville 1.882
Hong Kong 1.871
Seattle 1.747
Cambridge 1.595
Wilmington 1.379
Ann Arbor 1.362
Beijing 1.256
San Jose 1.134
The Dalles 1.080
Warsaw 954
Princeton 879
New York 808
Chandler 728
Los Angeles 645
Dallas 586
Helsinki 579
Chicago 515
Lauterbourg 490
Dublin 477
Nanjing 473
Istanbul 470
Ho Chi Minh City 411
Munich 301
Council Bluffs 300
Brescia 273
Buffalo 269
Des Moines 235
Redondo Beach 226
Hanoi 218
São Paulo 213
Milan 204
Dearborn 199
Moscow 198
Salt Lake City 193
Tallinn 191
San Diego 189
Nanchang 188
Shanghai 174
Changsha 154
Boardman 153
Santa Clara 146
San Francisco 145
Shenyang 141
London 134
Hebei 133
Orem 119
Turku 116
Tianjin 105
Jinan 94
Rio de Janeiro 91
Jakarta 88
Tampa 88
Rome 83
Tokyo 83
Elk Grove Village 82
Brno 80
Dong Ket 80
Brooklyn 78
Nuremberg 78
Secaucus 74
Jiaxing 70
Hangzhou 69
Stockholm 68
Belo Horizonte 66
Atlanta 64
Dalmine 64
Phoenix 64
Toronto 64
Montreal 61
Johannesburg 60
Chennai 57
Denver 57
Lappeenranta 57
Romola 57
Brasília 56
Frankfurt am Main 56
Orange 56
Verona 56
Kunming 54
Mexico City 54
Poplar 54
Da Nang 53
Guangzhou 53
Brussels 52
Lancaster 52
Kocaeli 51
Zhengzhou 51
Boston 50
Haiphong 47
Naples 46
Paris 46
Baghdad 45
Amsterdam 44
Tashkent 44
Curitiba 43
Totale 44.769
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 790
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 381
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 314
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 297
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 262
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 256
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 253
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 251
Excess of second tumors in denosumab-treated patients: A metabolic hypothesis 250
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 250
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 249
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 248
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 248
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† 241
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 228
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 228
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Pros-IT CNR: an Italian prostate cancer monitoring project 224
Immunotherapy failure in adrenocortical cancer: where next? 223
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 223
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 218
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 212
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 211
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 211
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 209
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 209
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 209
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 207
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer 204
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 203
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 202
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 201
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 199
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 197
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 195
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509) 194
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 193
Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer 192
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 192
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 190
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 189
Palbociclib inhibits proliferation of human adrenocortical tumor cells 189
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 189
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 187
Regression of advanced neuroendocrine tumors among patients receiving placebo 187
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 186
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 185
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 184
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 183
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 182
A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report 181
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 180
828PBONE METASTASES FROM RCC ARE NOT ALWAYS ASSOCIATED WITH A POOR PROGNOSIS 179
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 178
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 178
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 177
Effect of primary letrozole treatment on tumor expression of mTOR and HIF-1α and relation to clinical response 176
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 175
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients 175
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer. 173
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 173
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 173
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 173
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 173
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 173
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 171
A current perspective on treatment of adrenocortical carcinoma 170
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 170
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 168
Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi method 168
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 168
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 168
Exemestane with ovarian suppression in premenopausal breast cancer. 168
Serum vitamin D and prostate cancer prognosis: The story continues 167
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 167
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 167
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: A double-blind, randomised, phase 3 study 166
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 165
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors 164
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 164
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. 163
5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma 163
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 163
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† 163
Gonadal function in male patients with metastatic renal cell cancer treated with sunitinib: Effects of testosterone replacement on quality of life. 161
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 160
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors 158
An unusual case of a well-differentiated neuroendocrine tumour of the ileum with peritoneal carcinomatosis: A case report 156
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 156
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 155
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 155
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 155
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma 154
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 153
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 153
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 153
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 153
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 153
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 152
Abiraterone and increased survival in metastatic prostate cancer 151
Totale 19.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 325.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 325.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021385 0 0 0 0 0 0 0 0 0 0 0 385
2021/20223.503 274 702 93 213 50 182 214 234 194 349 267 731
2022/20232.586 497 83 74 178 191 712 10 212 347 44 115 123
2023/20243.948 180 96 316 217 207 696 109 145 1.039 118 48 777
2024/202510.895 98 74 98 1.510 1.168 737 591 293 1.088 803 2.697 1.738
2025/202620.192 1.636 2.770 1.934 3.138 1.553 1.223 2.697 784 1.253 1.786 954 464
Totale 67.588